Medartis (MDRSF) Short Interest Ratio & Short Volume C$51.70 0.00 (0.00%) As of 03/11/2025 Add Compare Share Share Short Interest Stock AnalysisChartShort Interest Medartis Short Interest DataMedartis (MDRSF) has a short interest of 163,600 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 300 shares to cover all short positions.Current Short Interest163,600 sharesPrevious Short Interest163,600 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$8.46 millionShort Interest Ratio0.0 Days to CoverLast Record DateFebruary 28, 2025Today's Trading Volume0 sharesAverage Trading Volume300 sharesToday's Volume Vs. Average0% Short Selling Medartis? Sign up to receive the latest short interest report for Medartis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMDRSF Short Interest Over TimeMDRSF Days to Cover Over TimeMDRSF Percentage of Float Shorted Over Time Remove Ads Medartis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/2025163,600 shares C$8.46 million No ChangeN/A0 $51.70 2/15/2025163,600 shares C$8.46 million No ChangeN/A0 $51.70 1/31/2025163,600 shares C$8.46 million +2.4%N/A0 $51.70 1/15/2025159,800 shares C$8.26 million -1.4%N/A0 $51.70 12/31/2024162,100 shares C$8.38 million +0.2%N/A0 $51.70 12/15/2024161,800 shares C$8.37 million +2.1%N/A0 $51.70 11/30/2024158,500 shares C$8.19 million -0.4%N/A1585 $51.70 11/15/2024159,200 shares C$10.62 million -0.3%N/A0 $66.68 10/31/2024159,600 shares C$10.64 million +0.6%N/A1596 $66.68 10/15/2024158,700 shares C$12.53 million No ChangeN/A0 $78.99 Get the Latest News and Ratings for MDRSF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medartis and its competitors with MarketBeat's FREE daily newsletter. 9/30/2024158,700 shares C$12.53 million -2.0%N/A0 $78.99 9/15/2024161,900 shares C$12.79 million -0.1%N/A0 $78.99 8/31/2024162,100 shares C$12.80 million -2.4%N/A0 $78.99 8/15/2024166,100 shares C$13.12 million -0.1%N/A1661 $78.99 7/31/2024166,300 shares C$13.99 million -0.7%N/A0 $84.10 7/15/2024167,400 shares C$14.08 million -0.5%N/A0 $84.10 6/30/2024168,300 shares C$14.15 million +1.0%N/A1683 $84.10 6/15/2024166,700 shares C$14.02 million -0.7%N/A0 $84.10 5/31/2024167,800 shares C$14.11 million -0.2%N/A0 $84.10 5/15/2024168,200 shares C$14.15 million -0.7%N/A1682 $84.10 4/30/2024169,400 shares C$13.21 million +0.2%N/A0 $77.96 4/15/2024169,100 shares C$13.18 million +6,163.0%N/A0 $77.96 3/31/20242,700 shares C$210,492.00 No ChangeN/A0 $77.96 3/15/20242,700 shares C$210,492.00 +22.7%N/A0 $77.96 2/29/20242,200 shares C$171,512.00 -4.4%N/A0 $77.96 2/15/20242,300 shares C$179,308.00 +21.1%N/A0 $77.96 1/15/20242,700 shares C$210,492.00 -10.0%N/A0 $77.96 12/31/20233,000 shares C$233,880.00 -11.8%N/A0 $77.96 12/15/20233,400 shares C$265,064.00 -29.2%N/A0 $77.96 11/30/20234,800 shares C$374,208.00 -30.4%N/A0 $77.96 11/15/20236,900 shares C$537,924.00 -2.8%N/A0 $77.96 10/31/20237,100 shares C$553,516.00 -7.8%N/A0 $77.96 10/15/20237,700 shares C$600,292.00 -3.8%N/A0 $77.96 9/30/20238,000 shares C$623,680.00 +8.1%N/A0 $77.96 9/15/20237,400 shares C$576,904.00 +64.4%N/A0 $77.96 8/31/20234,500 shares C$350,820.00 -42.3%N/A1125.5 $77.96 8/15/20237,800 shares C$608,088.00 +32.2%N/A78 $77.96 7/31/20235,900 shares C$459,964.00 +20.4%N/A0 $77.96 7/15/20234,900 shares C$382,004.00 +44.1%N/A0 $77.96 6/30/20233,400 shares C$265,064.00 -2.9%N/A0 $77.96Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.You MUST act before March 17th. 6/15/20233,500 shares C$272,860.00 +12.9%N/A0 $77.96 5/31/20233,100 shares C$241,676.00 +19.2%N/A31 $77.96 5/15/20232,600 shares C$192,036.00 No ChangeN/A26 $73.86 4/30/20232,600 shares C$192,036.00 -3.7%N/A0 $73.86 4/15/20232,700 shares C$199,422.00 -15.6%N/A0 $73.86 3/31/20233,200 shares C$236,352.00 -5.9%N/A32 $73.86 3/15/20233,400 shares C$200,600.00 +3.0%N/A0 $59.00 2/28/20233,300 shares C$194,700.00 +32.0%N/A0 $59.00 2/15/20232,500 shares C$147,500.00 No ChangeN/A0 $59.00 1/31/20232,500 shares C$147,500.00 No ChangeN/A0 $59.00 1/15/20232,500 shares C$147,500.00 -7.4%N/A25 $59.00 12/30/20222,700 shares C$159,300.00 -6.9%N/A27 $59.00 12/15/20222,900 shares C$171,100.00 -3.3%N/A0 $59.00 11/30/20223,000 shares C$177,000.00 -11.8%N/A30 $59.00 11/15/20223,400 shares C$200,600.00 -30.6%N/A0 $59.00 10/31/20224,900 shares C$289,100.00 +2.1%N/A0 $59.00 10/15/20224,800 shares C$283,200.00 -2.0%N/A0 $59.00 9/30/20224,900 shares C$289,100.00 -3.9%N/A0 $59.00 9/15/20225,100 shares C$300,900.00 +2.0%N/A0 $59.00 8/31/20225,000 shares C$295,000.00 +72.4%N/A0 $59.00 MDRSF Short Interest - Frequently Asked Questions What is Medartis' current short interest? Short interest is the volume of Medartis shares that have been sold short but have not yet been covered or closed out. As of February 28th, investors have sold 163,600 shares of MDRSF short. Learn More on Medartis' current short interest. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short Medartis stock? Short selling MDRSF is an investing strategy that aims to generate trading profit from Medartis as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Medartis? A short squeeze for Medartis occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MDRSF, which in turn drives the price of the stock up even further. How often is Medartis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MDRSF, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies BICO Group AB (publ) Short Interest Caliber Imaging & Diagnostics Short Interest CellaVision AB (publ) Short Interest Cochlear Short Interest Demant A/S Short Interest Drägerwerk AG & Co. KGaA Short Interest Electromedical Technologies Short Interest Embla Medical hf. Short Interest Evome Medical Technologies Short Interest GN Store Nord A/S Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MDRSF) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'Trump Orders ‘National Digital Asset Stockpile’ THIS could be the coin they choose…Crypto 101 Media | SponsoredDOGE’s Next Move: Not what you thinkDonald Trump, Elon Musk and the Department of Government Efficiency have kept their word. Moving even faste...Weiss Ratings | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medartis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Medartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
